Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 2/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | OGT | O15294 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9562478 | 0.94 | GRIN2B (0.60) | GRIN2BKCNH2BCHEACHEALDH1A1 | |
| SCHEMBL9562529 | 0.91 | KCNH2 (0.57) | GRIN2BKCNH2BCHEACHEMAOB | |
| SCHEMBL9562489 | 0.91 | KCNH2 (0.51) | GRIN2BKCNH2BCHEACHEALDH1A1 | |
| SCHEMBL9561877 | 0.90 | KCNH2 (0.52) | GRIN2BKCNH2BCHEACHEALDH1A1 | |
| SCHEMBL9562497 | 0.89 | KCNH2 (0.57) | GRIN2BKCNH2BCHEACHEALDH1A1 | |
| SCHEMBL8439768 | 0.84 | KCNH2 (0.54) | GRIN2BKCNH2ALDH1A1ATMOGT | |
| SCHEMBL9561894 | 0.84 | BCHE (0.50) | GRIN2BKCNH2BCHEACHEOGT | |
| SCHEMBL9562508 | 0.84 | MEN1 (0.44) | GRIN2BKCNH2BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL8542941 | 0.84 | MEN1 (0.56) | GRIN2BKCNH2ALDH1A1ATMOGT | |
| SCHEMBL9561851 | 0.84 | GRIN2B (0.56) | GRIN2BKCNH2ALDH1A1ATMOGT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5212181-A | 1-(3,4-dihydro-2-oxo-1H-quinolin-6-yl)-2-[4-(2-phenylethyl)piperidin-1-yl]et[4-(2-phenylethyl)piperidin-1-yl]ethanone, to their preparation and to their therapeutic application | SYNTHELABO (FR) | 1993-05-18 | — | — | US | claimed |
| EP-0481853-A1 | 1-(3,4-Dihydro-2-oxo-1H-quinoline-6-yl)-2-[4-(2-phenylethyl)-piperidin-1-yl]ethanol and -ethane, their preparation and their use in therapeutics | SYNTHELABO (FR) | 1992-04-22 | — | — | EP | claimed |
| EP-2600863-B1 | USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA | ESTEVE LABOR DR (ES) | 2018-03-28 | — | — | EP | disclosed |
| EP-2646025-B1 | USE OF SIGMA LIGANDS IN BONE CANCER PAIN | ESTEVE LABOR DR (ES) | 2017-03-15 | — | — | EP | disclosed |
| EP-2531191-B1 | Sigma ligands for use in the prevention and/or treatment of postoperative pain | ESTEVE LABOR DR (ES) | 2016-03-30 | — | — | EP | disclosed |
| EP-2571501-B1 | SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY | ESTEVE LABOR DR (ES) | 2016-03-02 | — | — | EP | disclosed |
| EP-2460519-A1 | Use of sigma ligands in bone cancer pain | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2012-06-06 | — | — | EP | disclosed |
| EP-2415471-A1 | Use of sigma ligands in opioid-induced hyperalgesia | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2012-02-08 | — | — | EP | disclosed |
| EP-2388005-A1 | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2011-11-23 | — | — | EP | disclosed |
| EP-2353598-A1 | Sigma ligands for use in the prevention and/or treatment of postoperative pain | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2011-08-10 | — | — | EP | disclosed |
| US-5212181-A | 1-(3,4-dihydro-2-oxo-1H-quinolin-6-yl)-2-[4-(2-phenylethyl)piperidin-1-yl]et[4-(2-phenylethyl)piperidin-1-yl]ethanone, to their preparation and to their therapeutic application | SYNTHELABO (FR) | 1993-05-18 | — | — | US | disclosed |
| EP-0481853-A1 | 1-(3,4-Dihydro-2-oxo-1H-quinoline-6-yl)-2-[4-(2-phenylethyl)-piperidin-1-yl]ethanol and -ethane, their preparation and their use in therapeutics | SYNTHELABO (FR) | 1992-04-22 | — | — | EP | disclosed |
| EP-0481853-A1 | 1-(3,4-Dihydro-2-oxo-1H-quinoline-6-yl)-2-[4-(2-phenylethyl)-piperidin-1-yl]ethanol and -ethane, their preparation and their use in therapeutics | SYNTHELABO (FR) | 1992-04-22 | — | — | EP | disclosed |